International measures to stop the spread of wild polio virus: update

10 November 2020

Article: 54/4502

On 14 October 2020, the 26th meeting of the Emergency Committee under the International Health Regulations (IHR) (2005) regarding the international spread of wild poliovirus, was convened by the World Health Organization (WHO). The committee agreed that the situation still constitutes a Public Health Emergency of International Concern (PHEIC) and recommended the extension of the temporary recommendations. 

The committee provided the director-general with updated risk categories as below:  

  • A certificate for polio vaccination under IHR (2005) is required for travellers from countries listed below, which are infected with WPV1, cVDPV1 or cVDPV3, with the potential risk of international spread: 

    • Afghanistan (WPV1)  
    • Malaysia (cVDPV1) 
    • Myanmar (cVDPV1) 
    • Pakistan (WPV1) 
    • Yemen (cVDPV1) 

  • While travellers are encouraged to carry proof of polio vaccination, there is no certificate requirement under IHR (2005) for countries listed below, which are infected with cVDPV2, with potential or demonstrated risk of international spread, with the exception of Afghanistan, Malaysia, Pakistan and the Philippines, which are also infected with WPV1 or cVDPV1: 

    • Afghanistan 
    • Angola 
    • Benin 
    • Burkina Faso 
    • Cameroon 
    • Central African Republic 
    • Chad 
    • Cote d’Ivoire 
    • Democratic Republic of Congo 
    • Ethiopia 
    • Ghana 
    • Guinea 
    • Malaysia 
    • Mali 
    • Niger 
    • Nigeria 
    • Pakistan 
    • Philippines 
    • Somalia 
    • South Sudan 
    • Sudan 
    • Togo 
    • Zambia 

  • States no longer infected by WPV1 or cVDPV, but which remain vulnerable to re-infection by WPV or cVDPV: 

    • China
    • Indonesia
    • Mozambique 
    • Myanmar
    • Papua New Guinea 

Advice for travellers and further information can be found on the TRAVAX (for health professionals) and fitfortravel (for the general public) websites.

Source: TRAVAX, 30 October 2020